Share:
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
SANTA FE, N. M., May 04, 2021 (GLOBE NEWSWIRE) Avisa Diagnostics Inc. (formerly, FogChain Corp.) (the Company ) is pleased to announce the closing of its previously announced reverse takeover transaction (the Transaction ) with Avisa Pharma Inc. ( Avisa ). In accordance with the merger agreement and plan of reorganization dated February 1, 2021 (the Merger Agreement ), which superseded and replaced the previously announced Letter of Intent dated January 12, 2021, the Transaction was effected by way of a triangular merger between the Company, Avisa, and a wholly owned, Delaware subsidiary of the Company ( Subco ) pursuant to the laws of the State of Delaware. The combined public company resulting from the Transaction (the Resulting Issuer ) will carry on the business of Avisa.